<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandin</z:chebi> (PG) E1 is a potent <z:chebi fb="1" ids="35620">vasodilator</z:chebi> on the peripheral vessels and also has an inhibitory action of platelet aggregation </plain></SENT>
<SENT sid="1" pm="."><plain>Thus it is expected that <z:chebi fb="0" ids="15544">PGE1</z:chebi> may be used for the treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Lipo-<z:chebi fb="0" ids="15544">PGE1</z:chebi>, the <z:chebi fb="23" ids="18059">lipid</z:chebi> emulsified <z:chebi fb="0" ids="15544">PGE1</z:chebi>, is not destroyed in the lung, has much longer half life in the circulation than <z:chebi fb="0" ids="15544">PGE1</z:chebi> which is rapidly inactivated in the lung </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of intravenous injection of lipo-<z:chebi fb="0" ids="15544">PGE1</z:chebi> on the cerebral hemodynamics and the central conduction time (CCT) of the sensory evoked potential under vasospastic conditions has been studied in eight patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these 8 patients demonstrated severe angiographic vasospasm and signs of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The 15-20 micrograms of lipo-<z:chebi fb="0" ids="15544">PGE1</z:chebi> was administered every eight hours for 5 to 7 days </plain></SENT>
<SENT sid="6" pm="."><plain>Within 6 hours of the first lipo-<z:chebi fb="0" ids="15544">PGE1</z:chebi> treatment, the regional cerebral blood flow (rCBF) and the CCT measurements were reported to document the effect of treatment </plain></SENT>
<SENT sid="7" pm="."><plain>The average pretreatment of rCBF on the right anterior, middle and posterior cerebral artery were 46.6 +/- 6.8, 56.4 +/- 7.3 and 58.8 +/- 8.9 ml/100 g/min and on the left side were 52.1 +/- 9.2, 49.1 +/- 10.8 and 56.1 +/- 9.2 ml/100 g/min respectively </plain></SENT>
<SENT sid="8" pm="."><plain>With treatment these flows increased to 53.0 +/- 6.9, 64.3 +/- 5.3 and 63.0 +/- 4.6 ml/100 g/min respectively on the right side and 60.8 +/- 9.4, 60.6 +/- 9.7 and 60.6 +/- 7.2 ml/100 g/min respectively on the left </plain></SENT>
<SENT sid="9" pm="."><plain>The CCT also demonstrated the improvement from 6.36 msec to 6.21 msec by the initial <z:chebi fb="0" ids="15544">PGE1</z:chebi> treatment.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>